Difference between revisions of "Event:937"
(Page created.) |
(selventa updated summary tables from widget page.) |
||
(22 intermediate revisions by 2 users not shown) | |||
Line 5: | Line 5: | ||
== Key Event Overview == | == Key Event Overview == | ||
− | Please follow link to [//{{SERVERNAME}}/events/{{PAGENAMEE}} widget page] to edit this section. <span style="color:#FF0000">'''If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.'''</span> | + | Please follow link to [//{{SERVERNAME}}/events/{{PAGENAMEE}} widget page] to edit this section. |
+ | |||
+ | <span style="color:#FF0000">'''If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.'''</span> | ||
=== AOPs Including This Key Event === | === AOPs Including This Key Event === | ||
Line 16: | Line 18: | ||
!Event Type | !Event Type | ||
!Essentiality | !Essentiality | ||
+ | |||
+ | |- | ||
+ | |||
+ | |[[Aop:149|Oxidative Stress Leading to Hypertension]]||KE||[[Aop:149#Essentiality of the Key Events|Strong]] | ||
|- | |- | ||
Line 29: | Line 35: | ||
!Evidence | !Evidence | ||
!Links | !Links | ||
+ | |||
+ | |- | ||
+ | |||
+ | |Homo sapiens||Homo sapiens||[[Event:937#Evidence Supporting Taxonomic Applicability|Strong]]||[http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=9606 NCBI] | ||
+ | |||
+ | |- | ||
+ | |||
+ | |Oryctolagus cuniculus||Oryctolagus cuniculus||[[Event:937#Evidence Supporting Taxonomic Applicability|Weak]]||[http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=9986 NCBI] | ||
+ | |||
+ | |- | ||
+ | |||
+ | |Mus musculus||Mus musculus||[[Event:937#Evidence Supporting Taxonomic Applicability|Moderate]]||[http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=10090 NCBI] | ||
+ | |||
+ | |- | ||
+ | |||
+ | |Rattus norvegicus||Rattus norvegicus||[[Event:937#Evidence Supporting Taxonomic Applicability|Moderate]]||[http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=10116 NCBI] | ||
|- | |- | ||
Line 39: | Line 61: | ||
!Biological Organization | !Biological Organization | ||
+ | |||
+ | |- | ||
+ | |||
+ | |Organ | ||
|- | |- | ||
Line 45: | Line 71: | ||
== How this Key Event works == | == How this Key Event works == | ||
+ | Vasodilation refers to the widening or increase in the diameter of blood vessels (e.g. large arteries, large veins, small arterioles) that is caused by the relaxation of vascular smooth muscle cells (VSMCs) within the walls of blood vessels, thus increasing blood flow and decreasing arterial blood pressure and heart rate (Siddiqui, 2011). VSMC relaxation is regulated through a number of mechanisms, including cyclic GMP-dependent hyperpolarization and relaxation via nitric oxide (NO), cAMP-dependent hyperpolarization via prostaglandins, and stimulation of potassium channels via endothelial-derived hyperpolarizing factors (Durand and Gutterman, 2013). Under oxidative stress, decreased NO bioavailability results in impaired vasodilation, which is associated with cardiovascular diseases such as hypertension (Silva et al., 2012). | ||
== How it is Measured or Detected == | == How it is Measured or Detected == | ||
− | + | Endothelium-dependent vasodilation can be measured using invasive and non-invasive methods (Raitakari and Celermajer, 2000). For the invasive approach, vasodilation is measured after intra-arterial pharmacologic stimulation with substances that enhance NO release (e.g. acetylcholine, bradykinin). The non-invasive ultrasound-based method evaluates flow-mediated vasodilation (FMD) in the superficial arteries, such as brachial, radial, or femoral vessels. | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
== Evidence Supporting Taxonomic Applicability == | == Evidence Supporting Taxonomic Applicability == | ||
+ | Vasodilation has been observed in humans, rabbits, mice and rats. | ||
== References == | == References == | ||
<references /> | <references /> | ||
+ | Durand, M.J., and Gutterman, D.D. (2013). Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirc. N. Y. N 1994 20, 239–247. | ||
+ | |||
+ | Raitakari, O.T., and Celermajer, D.S. (2000). Flow-mediated dilatation. Br. J. Clin. Pharmacol. 50, 397–404. | ||
+ | |||
+ | Siddiqui, A. (2011). Effects of Vasodilation and Arterial Resistance on Cardiac Output. J. Clin. Exp. Cardiol. 02. | ||
+ | |||
+ | Silva, B.R., Pernomian, L., and Bendhack, L.M. (2012). Contribution of oxidative stress to endothelial dysfunction in hypertension. Front. Physiol. 3, 441. |
Latest revision as of 13:51, 2 July 2016
Contents
Event Title
Key Event Overview
Please follow link to widget page to edit this section.
If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.
AOPs Including This Key Event
AOP Name | Event Type | Essentiality |
---|---|---|
Oxidative Stress Leading to Hypertension | KE | Strong |
Taxonomic Applicability
Name | Scientific Name | Evidence | Links |
---|---|---|---|
Homo sapiens | Homo sapiens | Strong | NCBI |
Oryctolagus cuniculus | Oryctolagus cuniculus | Weak | NCBI |
Mus musculus | Mus musculus | Moderate | NCBI |
Rattus norvegicus | Rattus norvegicus | Moderate | NCBI |
Level of Biological Organization
Biological Organization |
---|
Organ |
How this Key Event works
Vasodilation refers to the widening or increase in the diameter of blood vessels (e.g. large arteries, large veins, small arterioles) that is caused by the relaxation of vascular smooth muscle cells (VSMCs) within the walls of blood vessels, thus increasing blood flow and decreasing arterial blood pressure and heart rate (Siddiqui, 2011). VSMC relaxation is regulated through a number of mechanisms, including cyclic GMP-dependent hyperpolarization and relaxation via nitric oxide (NO), cAMP-dependent hyperpolarization via prostaglandins, and stimulation of potassium channels via endothelial-derived hyperpolarizing factors (Durand and Gutterman, 2013). Under oxidative stress, decreased NO bioavailability results in impaired vasodilation, which is associated with cardiovascular diseases such as hypertension (Silva et al., 2012).
How it is Measured or Detected
Endothelium-dependent vasodilation can be measured using invasive and non-invasive methods (Raitakari and Celermajer, 2000). For the invasive approach, vasodilation is measured after intra-arterial pharmacologic stimulation with substances that enhance NO release (e.g. acetylcholine, bradykinin). The non-invasive ultrasound-based method evaluates flow-mediated vasodilation (FMD) in the superficial arteries, such as brachial, radial, or femoral vessels.
Evidence Supporting Taxonomic Applicability
Vasodilation has been observed in humans, rabbits, mice and rats.
References
Durand, M.J., and Gutterman, D.D. (2013). Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirc. N. Y. N 1994 20, 239–247.
Raitakari, O.T., and Celermajer, D.S. (2000). Flow-mediated dilatation. Br. J. Clin. Pharmacol. 50, 397–404.
Siddiqui, A. (2011). Effects of Vasodilation and Arterial Resistance on Cardiac Output. J. Clin. Exp. Cardiol. 02.
Silva, B.R., Pernomian, L., and Bendhack, L.M. (2012). Contribution of oxidative stress to endothelial dysfunction in hypertension. Front. Physiol. 3, 441.